Ping-Fang Hu1, Xin Zeng2, Zi-Yuan Zou1,3, Wei Tang4, Yi-Bin Guo5, Zong-Li Yuan1, Pei-Mei Shi1, Yu Tan1, Yan Song4, Yong-Quan Shi4, Wei-Fen Xie1. 1. Department of Gastroenterology, Changzheng Hospital, Second Military Medical University, Shanghai, China. 2. Department of Gastroenterology, East Hospital, Tongji University School of Medicine, Shanghai, China. 3. The First Clinical School, Nanfang Hospital, Southern Medical University, Guangzhou, China. 4. Department of Endocrinology, Changzheng Hospital, Second Military Medical University, Shanghai, China. 5. Department of Health Statistics, Second Military Medical University, Shanghai, China.
Abstract
BACKGROUND: With lifestyle modification and over-nutrition, the prevalence of nonalcoholic fatty liver disease (NAFLD) has been increasing annually. Here we aimed to assess the updated prevalence of NAFLD, and to evaluate the association of NAFLD with metabolic abnormalities according to gender, body mass index and age. METHODS: A population-based cross-sectional study was conducted in Shanghai from December 2016 to July 2017. With a three-stage stratified sampling strategy, 3,717 eligible participants were enrolled for the analysis. RESULTS: In total, 1,217 subjects (32.7%) had NAFLD. Among them, 400 (16.3%) of the nonobese and 817 (65.0%) of the obese subjects had NAFLD. The prevalence of NAFLD was increased according to the quartiles of age and waist circumference (WC) in the nonobese subjects. Females with nonobese NAFLD had 1.6-, 2.6-, 2.0-, 2.3- and 3.3-fold higher risks for metabolic syndrome, diabetes mellitus, hyperglycemia, hypertriglycerdemia (high TG) and low high-density lipoprotein cholesterol than obese subjects without NAFLD, respectively. Males had comparable metabolic profiles in both groups, except for a 2.0-fold higher risk of high TG in nonobese NAFLD subjects compared with obese subjects without NAFLD. More impressively, the homeostasis metabolic assessment insulin resistance index was comparable between the two groups. CONCLUSIONS: The increase of age and WC had significant impact on the risk of NAFLD in nonobese subjects. The presence of NAFLD in nonobese subjects increased the risk of metabolic diseases than obese subjects without NAFLD, especially in female. 2021 Hepatobiliary Surgery and Nutrition. All rights reserved.
BACKGROUND: With lifestyle modification and over-nutrition, the prevalence of nonalcoholic fatty liver disease (NAFLD) has been increasing annually. Here we aimed to assess the updated prevalence of NAFLD, and to evaluate the association of NAFLD with metabolic abnormalities according to gender, body mass index and age. METHODS: A population-based cross-sectional study was conducted in Shanghai from December 2016 to July 2017. With a three-stage stratified sampling strategy, 3,717 eligible participants were enrolled for the analysis. RESULTS: In total, 1,217 subjects (32.7%) had NAFLD. Among them, 400 (16.3%) of the nonobese and 817 (65.0%) of the obese subjects had NAFLD. The prevalence of NAFLD was increased according to the quartiles of age and waist circumference (WC) in the nonobese subjects. Females with nonobese NAFLD had 1.6-, 2.6-, 2.0-, 2.3- and 3.3-fold higher risks for metabolic syndrome, diabetes mellitus, hyperglycemia, hypertriglycerdemia (high TG) and low high-density lipoprotein cholesterol than obese subjects without NAFLD, respectively. Males had comparable metabolic profiles in both groups, except for a 2.0-fold higher risk of high TG in nonobese NAFLD subjects compared with obese subjects without NAFLD. More impressively, the homeostasis metabolic assessment insulin resistance index was comparable between the two groups. CONCLUSIONS: The increase of age and WC had significant impact on the risk of NAFLD in nonobese subjects. The presence of NAFLD in nonobese subjects increased the risk of metabolic diseases than obese subjects without NAFLD, especially in female. 2021 Hepatobiliary Surgery and Nutrition. All rights reserved.
Authors: Naga Chalasani; Zobair Younossi; Joel E Lavine; Michael Charlton; Kenneth Cusi; Mary Rinella; Stephen A Harrison; Elizabeth M Brunt; Arun J Sanyal Journal: Hepatology Date: 2017-09-29 Impact factor: 17.425
Authors: Alexandra Feldman; Sebastian K Eder; Thomas K Felder; Lyudmyla Kedenko; Bernhard Paulweber; Andreas Stadlmayr; Ursula Huber-Schönauer; David Niederseer; Felix Stickel; Simon Auer; Elisabeth Haschke-Becher; Wolfgang Patsch; Christian Datz; Elmar Aigner Journal: Am J Gastroenterol Date: 2016-08-16 Impact factor: 10.864
Authors: Javier Ampuero; Rocío Aller; Rocío Gallego-Durán; Jesus M Banales; Javier Crespo; Carmelo García-Monzón; María Jesús Pareja; Eduardo Vilar-Gómez; Juan Caballería; Desamparados Escudero-García; Judith Gomez-Camarero; José Luis Calleja; Mercedes Latorre; Agustín Albillos; Javier Salmeron; Patricia Aspichueta; Oreste Lo Iacono; Rubén Francés; Salvador Benlloch; Conrado Fernández-Rodríguez; Javier García-Samaniego; Pamela Estévez; Raúl J Andrade; Juan Turnes; Manuel Romero-Gómez Journal: Aliment Pharmacol Ther Date: 2018-10-23 Impact factor: 8.171
Authors: Yangbo Sun; Buyun Liu; Linda G Snetselaar; Robert B Wallace; Bette J Caan; Thomas E Rohan; Marian L Neuhouser; Aladdin H Shadyab; Rowan T Chlebowski; JoAnn E Manson; Wei Bao Journal: JAMA Netw Open Date: 2019-07-03